Colonic health: fermentation and short chain fatty acids
- PMID: 16633129
- DOI: 10.1097/00004836-200603000-00015
Colonic health: fermentation and short chain fatty acids
Abstract
Interest has been recently rekindled in short chain fatty acids (SCFAs) with the emergence of prebiotics and probiotics aimed at improving colonic and systemic health. Dietary carbohydrates, specifically resistant starches and dietary fiber, are substrates for fermentation that produce SCFAs, primarily acetate, propionate, and butyrate, as end products. The rate and amount of SCFA production depends on the species and amounts of microflora present in the colon, the substrate source and gut transit time. SCFAs are readily absorbed. Butyrate is the major energy source for colonocytes. Propionate is largely taken up by the liver. Acetate enters the peripheral circulation to be metabolized by peripheral tissues. Specific SCFA may reduce the risk of developing gastrointestinal disorders, cancer, and cardiovascular disease. Acetate is the principal SCFA in the colon, and after absorption it has been shown to increase cholesterol synthesis. However, propionate, a gluconeogenerator, has been shown to inhibit cholesterol synthesis. Therefore, substrates that can decrease the acetate: propionate ratio may reduce serum lipids and possibly cardiovascular disease risk. Butyrate has been studied for its role in nourishing the colonic mucosa and in the prevention of cancer of the colon, by promoting cell differentiation, cell-cycle arrest and apoptosis of transformed colonocytes; inhibiting the enzyme histone deacetylase and decreasing the transformation of primary to secondary bile acids as a result of colonic acidification. Therefore, a greater increase in SCFA production and potentially a greater delivery of SCFA, specifically butyrate, to the distal colon may result in a protective effect. Butyrate irrigation (enema) has also been suggested in the treatment of colitis. More human studies are now needed, especially, given the diverse nature of carbohydrate substrates and the SCFA patterns resulting from their fermentation. Short-term and long-term human studies are particularly required on SCFAs in relation to markers of cancer risk. These studies will be key to the success of dietary recommendations to maximize colonic disease prevention.
Similar articles
-
Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease.Scand J Gastroenterol Suppl. 1996;216:132-48. doi: 10.3109/00365529609094568. Scand J Gastroenterol Suppl. 1996. PMID: 8726286 Review.
-
Short chain fatty acids and colonic health.Bratisl Lek Listy. 2007;108(8):354-8. Bratisl Lek Listy. 2007. PMID: 18203540 Review.
-
Short-chain fatty acids: ready for prime time?Nutr Clin Pract. 2006 Aug;21(4):351-66. doi: 10.1177/0115426506021004351. Nutr Clin Pract. 2006. PMID: 16870803 Review.
-
Intestinal health functions of colonic microbial metabolites: a review.Benef Microbes. 2011 Jun;2(2):103-14. doi: 10.3920/BM2011.0003. Benef Microbes. 2011. PMID: 21840809 Review.
-
Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer.Adv Exp Med Biol. 1999;472:149-58. doi: 10.1007/978-1-4757-3230-6_13. Adv Exp Med Biol. 1999. PMID: 10736623 Review.
Cited by
-
Novel therapeutic strategy for obesity through the gut microbiota-brain axis: A review article.Caspian J Intern Med. 2024 Spring;15(2):215-227. doi: 10.22088/cjim.15.2.215. Caspian J Intern Med. 2024. PMID: 38807723 Free PMC article. Review.
-
A metagenomic approach to unveil the association between fecal gut microbiota and short-chain fatty acids in diarrhea caused by diarrheagenic Escherichia coli in children.Microb Cell. 2024 Apr 30;11:116-127. doi: 10.15698/mic2024.04.820. eCollection 2024. Microb Cell. 2024. PMID: 38799407 Free PMC article.
-
Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications.Life (Basel). 2024 Apr 26;14(5):559. doi: 10.3390/life14050559. Life (Basel). 2024. PMID: 38792581 Free PMC article. Review.
-
Interaction between the gut microbiota and colonic enteroendocrine cells regulates host metabolism.Nat Metab. 2024 Jun;6(6):1076-1091. doi: 10.1038/s42255-024-01044-5. Epub 2024 May 22. Nat Metab. 2024. PMID: 38777856
-
The Role of Prebiotics in Modulating Gut Microbiota: Implications for Human Health.Int J Mol Sci. 2024 Apr 29;25(9):4834. doi: 10.3390/ijms25094834. Int J Mol Sci. 2024. PMID: 38732060 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources